A detailed history of Pictet Asset Management Holding Sa transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 805,103 shares of NTLA stock, worth $18 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
805,103
Previous 883,470 8.87%
Holding current value
$18 Million
Previous $26.9 Million 17.78%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$23.82 - $32.8 $1.87 Million - $2.57 Million
-78,367 Reduced 8.87%
805,103 $22.1 Million
Q4 2023

Feb 13, 2024

SELL
$23.16 - $32.34 $1.25 Million - $1.74 Million
-53,847 Reduced 5.74%
883,470 $26.9 Million
Q3 2023

Nov 14, 2023

BUY
$31.62 - $45.78 $29.6 Million - $42.9 Million
937,317 New
937,317 $29.6 Million

Others Institutions Holding NTLA

About Intellia Therapeutics, Inc.


  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.7B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.